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Abstract
Several systems have been presented in the last years in order to manage the complexity of large
microarray experiments. Although good results have been achieved, most systems tend to lack in
one or more fields. A Grid based approach may provide a shared, standardized and reliable solution
for storage and analysis of biological data, in order to maximize the results of experimental efforts.
A Grid framework has been therefore adopted due to the necessity of remotely accessing large
amounts of distributed data as well as to scale computational performances for terabyte datasets.
Two different biological studies have been planned in order to highlight the benefits that can
emerge from our Grid based platform. The described environment relies on storage services and
computational services provided by the gLite Grid middleware. The Grid environment is also able
to exploit the added value of metadata in order to let users better classify and search experiments.
A state-of-art Grid portal has been implemented in order to hide the complexity of framework
from end users and to make them able to easily access available services and data. The functional
architecture of the portal is described. As a first test of the system performances, a gene expression
analysis has been performed on a dataset of Affymetrix GeneChip®  Rat Expression Array
RAE230A, from the ArrayExpress database. The sequence of analysis includes three steps: (i) group
opening and image set uploading, (ii) normalization, and (iii) model based gene expression (based
on PM/MM difference model). Two different Linux versions (sequential and parallel) of the dChip
software have been developed to implement the analysis and have been tested on a cluster. From
results, it emerges that the parallelization of the analysis process and the execution of parallel jobs
on distributed computational resources actually improve the performances. Moreover, the Grid
environment have been tested both against the possibility of uploading and accessing distributed
datasets through the Grid middleware and against its ability in managing the execution of jobs on
distributed computational resources. Results from the Grid test will be discussed in a further paper.
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Background
It is well known that genomics and proteomics experi-
ments are associated with various and complex laboratory
protocols that need to be described in great detail, regard-
ing substances, procedures and conditions used. The large
amount of data generated by these experiments requires
extensive computational efforts to be interpreted and to
produce accurate and biologically consistent predictions.
For these reasons, exploitation of gene expression data is
fully dependent on the availability and sharing of (i) large
sets of genomic and proteomic data and (ii) advanced sta-
tistical analysis tools, both being typically collected by
distributed databases and providers, and structured under
different standards [1]. Therefore, integrative web based
services packages are often used in order to provide biolo-
gists and bioinformatics with a set of algorithms and serv-
ices covering the whole range of steps in microarray data
analysis. As measurements from experiments can dramat-
ically range in their accuracy and reproducibility, with
increasing emphasis on modelling error information,
researchers are used to design experiments with more bio-
logical replicates [2]. Statistical processing systems can
overcome this problem by widening the amount of data
they are able to consider, but very large datasets are
required to achieve satisfactory results [3,4]. However,
cost is a strong limit on the size of experiments. As a solu-
tion, similar data may be collected across several acquisi-
tion facilities, but side conditions associated to
experiments must be tracked in order to be able to repro-
duce or compare different experimental setups [5]. Fur-
thermore, end-users may be provided with different
analysis algorithms by different providers, and search
tools may be needed to find data and applications. Even-
tually, data or experimental setups as well as results from
experiments may be collected through a user-friendly web
interface. To complete this approach, modular and inde-
pendent applications may be published on a portal, and
either single algorithms or a combination of them may be
invoked remotely by users, through a workflow strategy
[6].
Due to these reasons, several systems have been presented
in the last years in order to manage the complexity of big
microarray experiments. Although good results have been
achieved, each system tends to lack in one or more fields.
The MARS system [5] may keep track of information col-
lected during microarray experiments, with special
emphasis on quality management and process control.
Several applications for storing, retrieving, and analysing
microarray data may be connected through a web service
infrastructure. Thanks to the use of ontologies and to
standard definitions, studies performed by MARS may be
exported to public repositories; however neither data nor
applications can be accessed remotely, regardless of SOAP
used as internal protocol. XPS [7] is a distributed system
for microarray storage and analysis. XPS is intended as a
data warehouse and data mining system in the terabyte
realm and, based on the ROOT framework [8], it is sup-
posed to run in a Grid context. However, ROOT is an
intrinsic part of the system and XPS fully depends on the
availability of ROOT all around the Grid infrastructure.
The ODD/Genes system [9] provides some basic microar-
ray analysis tools together with a knowledge discovery
module and it is mostly based on Sun Microsystems Grid
components. It has also the ability to manage workflows
for microarray data and to distribute jobs on different
resources, but it heavily depends on Sun Technology
framework and it has not been tested on a real Grid infra-
structure.
Results
Grid architecture
A Grid based approach may provide a shared, standard-
ized and reliable solution for storage and analysis of the
afore-mentioned biological data, in order to maximize the
results of experimental efforts. Services may be imple-
mented within an existing Grid computing infrastructure
to solve problems concerning both large datasets storage
(data intensive problem) and large computational time
(computing intensive problem). A Grid framework has
been adopted due to the necessity of remotely accessing
large amounts of distributed data. Moreover, although
clusters may be computationally more efficient for small
data sets, they are hardly able to scale performances in ter-
abytes scenarios.
As further element of the architecture, a Grid portal may
allow unpractised users to store their experimental data
on a complex storage system and to access distributed data
and services. Eventually, security and privacy issues can be
addressed using a certificate-based authentication schema
coming out for free from the Grid technology. Handling
biomedical data is a challenging task because users have
(i) to store data on secure and reliable repositories and (ii)
to describe their data in order to be able to retrieve them
whenever requested. Instead of developing a database, we
decided to implement a Grid-based data storage and man-
agement system. The functional structure of the environ-
ment is described in Figure 1. Functions provided by the
Grid infrastructure are hidden from users interacting
through the portal to submit or search for data (images,
parameters, metadata) and applications.
A state-of-art Grid portal is being implementing in order
to hide the complexity of framework from end users and
to make them able to easily access available services and
data. Usability had been kept in mind in designing and
implementing the interface, and a really common model
has been adopted, which presents a menu with available
tools and services on the left and main contents in theBMC Bioinformatics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2105/8/S1/S7
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middle of the page. This way, the Grid portal, from the
user perspective view, is not different from the most used
Web-based applications.
The portal (Figure 2) consists in an HTTP server that pro-
vides contents by means of queries to metadata catalogues
and as a result of data processing. Through the portal users
communicate with the available data and computation
resources. The following functions may be provided to the
users:
￿ upload of data files with related permissions and meta-
data
￿ search of data files through queries on metadata
￿ list of available algorithms (both local and remote)
￿ creation of a virtual experiment by associating data and
algorithms
￿ interactive definition of parameters
￿ asynchronous running of experiments
￿ control on the status of experiments
￿ visualization of results
￿ download of results
The proposed architecture Figure 1
The proposed architecture. On the left, components visible to users, information flow and data are shown. On the right, the 
complexity of the Grid infrastructure (security framework omitted) is totally abstracted by the Grid portal.BMC Bioinformatics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2105/8/S1/S7
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With the aid of the portal, administrators can also manage
and upgrade information concerning data, algorithms
and users.
The portal itself is a Web application written in Java,
exposing Java servlets and interacting, through API, with
system commands or with services. Interfaces to users may
be represented either as a traditional GUI, exposing all
available services, or as WSDL pages exposing only some
Web Services. Relative to the inputs, the portal has been
planned to transform the HTTP requests submitted
through the portlets on the interface into XML messages
to the server components. Regarding the outputs, the
server components, after accessing resources, return XML
messages to the portlets. Such messages are then trans-
lated in HTML and updated pages are visualized according
to the AJAX paradigm [12].
A general use case
As an example, a general use case scenario is described as
follows. The user logs into the portal with his/her user-
name, password and a PIN code. Then he/she can access
two different kinds of services: data management and
processing. Through the data management tool, user data
can be uploaded to the application (actually they are
stored into a Grid storage element) and some mandatory
description fields are filled in (data to be stored into the
metadata catalog). From now on, data are accessible
through a search tool. Through this tool, users can then
select distributed data, corresponding to their search crite-
ria, coming from several experiments done at different
laboratories. Such data can then be processed, as a unique
distributed experiment, both locally and on the Grid, by
using computation services (custom as well as made avail-
able by third parts) deployed through the portal.
As regards microarray experiments, a number of analysis
tools are already available. The sequence of these tools
just provides a first validation pipeline for our framework
but also experiments from different fields of data analysis
(medical imaging, signal processing, etc.) may be consid-
ered. For the moment, forthcoming microarrays process-
ing tools include (i) group opening and image set
uploading, (ii) normalization, and (iii) model based gene
expression (based on PM/MM difference model). They are
all based on dChip software [13]. A further tool providing
the definition of differentially expressed genes is planned
but is not available yet. Other tools, typical of the bioin-
formatics community, like a workflow management sys-
tem and tools to query and use online resources (data
bank, web services) are planned together with the integra-
tion and availability of R/Bioconductor based tools [14].
Architectural design of the portal Figure 2
Architectural design of the portal.BMC Bioinformatics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2105/8/S1/S7
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According to our approach, available applications are pro-
vided as grid services exploiting the standard Grid infra-
structure (authentication, inter-process communication,
data management, job scheduling). To complete this Grid
approach, monitoring and account services are planned
for analyzing usage and performance on the Grid itself.
Real world scenarios
Without losing generalization, two different scenarios
have been considered in order to highlight the benefits
that can emerge from our Grid based platform. Firstly, the
mRNA expression profiles from the human umbilical vein
endothelial cells (HUVEC) treated with three different
types of interferons (IFNs) are under study. IFNs are
highly pleiotropic cytokines displaying marked ang-
iogenic activity and thus a promising therapeutic activity
in many tumor models. This remarkable anti-tumor activ-
ity has been related to various mechanisms such as direct
inhibition of tumor growth and induction of differentia-
tion and apoptosis, stimulation of specific cellular
immune response and inhibition of angiogenesis.
To date the gene expression profile induced by IFNs has
been studied mainly in tumor cell lines and some primary
cells [15], and little is known about the effects induced by
IFNs in endothelial cells compared to other cell types. The
definition of cell-type specific profiles emerges therefore
as an issue of paramount importance for a fully under-
standing of the biology of IFNs and their anti-angiogenic
activity. To reveal this, 9 total experiments have been per-
formed and gene profiles will be analyzed through our
platform including HUVEC cells either from controls cells
or from cells treated with recombinant human IFN-a, IFN-
b and IFN-c. All cells were processed by using Affymetrix
GeneChip HG-U133A microarrays.
The second scenario deals with a different cell-type, the
adult human bone marrow derived Stem Cells (SCs). SCs
are defined as self-renewal, multipotent progenitor cells
with the capacity to differentiate into several distinct cell
lineages. In adults of multiple vertebrate species, the bone
marrow represents the natural source of Mesenchymal
Stem Cells (MSC) and of Haemophoietic Stem Cells
(HMS). The properties of MSCs, such as clonogenicity,
phenotype and activities, are deeply influenced by the
microenvironment cues they are subjected to. Our tissue
engineering group is currently performing various experi-
ments including a three-dimensional (3D) perfusion bio-
reactor system and the typical monolayer (2D) for cell
expansion, in order to better prepare progenitors cells to
their in vivo tissue generation and repair. It has been
shown [16,17] that a 3D micro-environment could pro-
vide a significant increase in MSC clonogenicity mainte-
nance, a cell-matrix interaction enhancing, an in-vitro
osteogenic differentiation enhancing, and a higher in vivo
bone forming efficiency. To further investigate this fea-
tures, genes profiles of the human bone marrow MSCs
expanded either in 3D structures or in 2D ones will be
analyzed through our platform by using the Affymetrix
GeneChip HG-U133A microarrays, to try to identify genes
responsible of the clonogenicity maintenance.
Performance tests
A gene expression analysis concerning 15928 genes has
been performed on a dataset with 258 arrays of Affymetrix
GeneChip®  Rat Expression Array RAE230A, from the
ArrayExpress database. The sequence of analysis includes
three steps: (i) group opening and image set uploading,
(ii) normalization, and (iii) model based gene expression
(based on PM/MM difference model).
First of all, in order to be able to exploit distributed com-
putational resources, two different Linux versions of
dChip have been developed. The first one sequentially
reproduces the procedure as described above, while the
second one, a parallel version of the former one, has been
designed and implemented in order to improve the over-
all execution time. This has been achieved by splitting the
code into different parallel modules as follows.
The first module carries out the uploading of the microar-
ray images and their normalization based on invariant set
method, while the second one performs the PM/MM gene
expression extraction. A further module running the defi-
nition of differentially expressed genes has not been
implemented yet. The first module had been parallelized
against "array": each normalization job take into account
only the base array and one or more array from the data-
set. We can launch at most N-l normalization jobs where
N is the size of the dataset. The second module needs to
work on every normalized array because of its intrinsic
statistical nature. Starting from this point of view, it has
been parallelized against "genes". This means that each
job takes M (few hundreds to few thousands) genes from
each array and K processing jobs can be run (where M is
NumberOfGenesInEachArray/K). The implemented par-
allelization is a coarse grained one. Data have been dis-
tributed on different jobs but algorithms have not been
modified because they have been already validated by the
research community and therefore they do not have to be
handed.
To test the feasibility of this parallel implementation, a
comparison has been carried out between the two ver-
sions. The serial version has been executed on a Xeon 2.4
GHz processor and execution times were: 22'40" for step
(i) + (ii), and 14'19" for steps (iii). These times are meas-
ured with dChip internal timings on algorithm steps. As
regards the parallel version, the same three steps of the
analysis sequence have been executed on a local clusterBMC Bioinformatics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2105/8/S1/S7
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with 7 different machines (1 Xeon 2.0 GHz, 4 Xeon 2.4
GHz, 1 Pentium4 3 GHz, 1 Athlon 3000). Execution times
were: 2'14" for step (i) + (ii), 3'16" for steps (iii). Also
these times are measured with dChip internal timings on
algorithm steps.
The overall execution times resulted: 36'59" for the serial
implementation, and 5'30" for the parallel implementa-
tion on the cluster. Therefore, being T(l) the execution
time on a single processor, and T(N) the execution time
on N different processors (in our case N = 7), the speedup
ratio S(N) = T(l)/T(N) is 2219 sec/330 sec = 6.72, that is
very close to the ideal one.
From these results, it emerges that actually the paralleliza-
tion of the analysis process and the execution of parallel
jobs on distributed computational resources improve the
performances. It is worth noting that these results have
been obtained through the parallelization of the code "as
is", without refining the dChip implementation. This
means that MPI (Message Passing Interface) has been used
only to parallelize the running of jobs on different
machines without porting the whole code to MPI.
Improvements in execution times and robustness are then
expected from the full porting of code to MPI in order to
exploit its flexibility in automatically managing job allo-
cation among different worker nodes and job communi-
cation.
As a final test, the Grid environment is being tested both
against the possibility of uploading and accessing distrib-
uted datasets through the Grid middleware and against its
ability in managing the execution of jobs on distributed
computational resources.
The same analysis on the same dataset described above is
still in progress on the Grid environment. Tests are being
carried out both on the BIOMED infrastructure [18] and
on the GILD A test-bed [19]. The up-to-now results of
these tests are not sound enough and further improve-
ments are required. For this reason it is decided not to
publish them in this paper. A further paper is planned in
order to describe the statistical comparison among imple-
mentations on different clusters and on different Grid
infrastructures with special attention paid to the scaling of
performances according to the dimensions of datasets.
However, a number of general considerations may be
stated as references for this ongoing comparison:
- the parallel implementation on the cluster is likely to be
more efficient for very small experiments
- Grid job submission times due to queues on over-
crowded infrastructures may influence execution times.
However, job submission time can be considered as a con-
stant within the overall execution time, and therefore it
may become less influential as the size of the dataset
increases
- although clusters seem to provide better performances
for small datasets, they are hardly able to tackle the com-
putational challenges of huge bioinformatics problems.
As an example, the first module of our application can be
parallelized up to N-l jobs where N is the number of input
arrays (usually several thousands). A Grid environment
may provide enough CPUs to carry out this scaling but a
cluster easily may not.
- data from bioinformatics experiments, as well as services
for analysis, are usually located on geographically distrib-
uted resources. The Grid framework has been adopted
mainly due to its ability to remotely access this large
amount of distributed data and resources. A cluster
approach is intrinsically unable to provide such function-
alities.
Conclusion
Distributed microarray experimental data and applica-
tions may be uploaded and/or searched through the Grid
environment described in the paper. Users have only to
fill in data describing experiments and then they may use
the environment to access microarray bioinformatics serv-
ices for data management and data storage or to access
processing facilities on the Grid. A number of analysis
functions are provided: users can run basic processing on
data, have a look at intermediate results or come directly
to more general conclusions by looking at gene expression
levels. Moreover, analysis can be performed just on data
provided by the user or also on data coming from other
researchers, thus widening the size of available datasets
and increasing the possibility of obtaining statistically sig-
nificant results. On the other hand, distributed computing
resources may be used to dramatically reduce computa-
tional times for complex experiments. Eventually, bioin-
formatics data suppliers are provided with a secure and
reliable repository for their data and applications as well
as researchers are provided with a collection of data and
tools for unsupervised data processing, through a simple
web based portal interface. Very basic bioinformatics
skills are required to access the environment through the
portal, allowing also clinical and industrial users to hire
services on demand for both data storage and processing.
Through our Grid platform, a gene expression analysis
based on microarray experiments is planned for the two
real world scenarios described above.
Performance tests have been carried out on a dataset with
258 arrays of Affymetrix GeneChip® Rat Expression Array
RAE230A, from the ArrayExpress database. Three steps ofBMC Bioinformatics 2007, 8(Suppl 1):S7 http://www.biomedcentral.com/1471-2105/8/S1/S7
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the analysis sequence have been taken into account: (i)
uploading of the image data set, (ii) normalization, (iii)
model based gene expression.
For these steps, tests produced very promising results for
job parallelization on a small cluster, with a speedup ratio
of 6.72. Further improvements are expected from the full
porting of code to MPI and from tests on the fourth step
of analysis sequence.
As regards the ongoing tests for the Grid implementation,
some considerations are needed. In bioinformatics, real
world scenarios, data and services have to be collected
from geographically distributed resources. Only a Grid
framework may remotely access these resources in an effi-
cient and safe way, whereas a cluster approach may not.
Although Grid execution times are influenced by the job
submission queues on infrastructures, these submission
times do not change with the increase in the size of data-
sets and therefore their relative contribution to overall
execution times should decrease for large amounts of
data. More efficient and powerful Grid infrastructures
may greatly reduce the overload of these submission
times. On the other hand, clusters may hardly provide the
computational resources (thousands of CPUs) needed in
large bioinformatics experiments.
Starting from these considerations, only a Grid approach
seems to be suitable for the bioinformatics experiments
we are dealing with.
Methods
The described environment relies on storage services
(with replication and catalog services) and computational
services provided by the gLite Grid middleware [10]. gLite
middleware has been selected for the architecture as the
official Grid middleware for the Italian Grid infrastructure
and for the EC funded EGEE (Enabling Grids for E-sci-
encE) project. gLite is composed of a Workload Manage-
ment System (WMS), a Data Management System (DMS),
an Information System (IS) and various monitoring and
installation services. Services of the WMS are responsible
for the acceptance of submitted jobs and for sending them
to the appropriate Computing Elements (depending on
job requirements and available resources). The Comput-
ing Element (CE) is the Grid interface to a computing
cluster and it is defined as a Grid batch queue. The CPUs
to be allocated are automatically selected by the Resource
Broker (RB) which is the machine where the WMS services
run. The User Interface (UI) is the component that allows
users to access functionalities of the WMS. Concerning the
data management, the DMS relies on two kinds of serv-
ices: the LCG File Catalog (LFC) and the Storage Element
(SE). LFC provides a global hierarchical namespace of
Logical File Names (LFNs), which are mapped to physical
file names usually stored on a SE. Data are stored on dis-
tributed SEs through a script which automatically loads
data. At the present time, single copies of data are saved,
but several replicas could be done to improve perform-
ances. Actually, the Grid environment is also able to
exploit the added value of metadata in order to let users
better classify and search experiments. A very flexible use
of metadata is provided by associating them with LFNs,
through the AMGA metadata server: every user can have
his/her own metadata associated with a file or have differ-
ent metadata associated with a file depending on the con-
text. Collected metadata are associated to files stored on
Grid through a reference on the LFC catalog system. This
way, user information with a special format (VOMS cre-
dential) can be mapped to AMGA roles and users can
access metadata collections. To this goal, a full security
x.509 certificates based framework [11], with Access Con-
trol Lists on data and processes, has been deployed in
order to guarantee security and auditing. Eventually,
through the IS, CEs suitable to run jobs can be located,
and SEs holding replicas of Grid files together with the cat-
alogs that keep information of these files can be found.
Therefore data are not sent with jobs but they are retrieved
from SEs through logical names by using GFAL API.
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